权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Metabolic control in vascular remodeling

血管重塑中的代谢控制

基本信息

批准号：
10543542
负责人：
Nicholas E Sibinga
金额：
$ 59.36万
依托单位：
ALBERT EINSTEIN COLLEGE OF MEDICINE
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-03-01 至 2025-01-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10543542
关键词：
Address Adult Affect Animals Aorta Area Arterial Injury Arteries Arteriosclerosis Aspartate Atherosclerosis Biological Assay Blood Vessels Cadherins Cardiovascular Diseases Cause of Death Cell Proliferation Cell Wall Cell division Cell physiology Cells Cellular Metabolic Process Cellular biology Complex DNA Damage Data Development Disease Dorsal Elements Embryo Embryonic Development Endothelial Cells Extracellular Matrix FAT gene Frequencies Functional disorder Genetic Goals Growth Health Homeostasis Impairment Injury Intervention Invaded Knowledge Label Longevity Mediating Metabolic Control Metabolism Mitochondria Mitochondrial DNA Modeling Mus NADH dehydrogenase (ubiquinone)Neurons Obstruction Oxidative Phosphorylation Oxygen Consumption Pathogenesis Pathogenicity Pathology Phenotype Play Population Predisposition Preventive Process Proliferating Proteins Reactive Oxygen Species Regulation Research Respiration Role Smooth Muscle Myocytes Structure Testing Therapeutic Time Tissue Engineering Transplantation Tube Vascular Diseases Vascular Smooth Muscle Vascular remodeling Vascularization angiogenesis cell behavior cell growth clinically significant cytokine disability in vivo mechanical force metabolic phenotype migration mouse development mouse model novel oxidation pharmacologic postnatal prevent repaired respiratory response restenosis restraint screening therapeutic angiogenesis tumor vascular injury vasculogenesis

项目摘要

Summary Vascular remodeling is essential for artery formation during embryogenesis and in the pathogenesis of vascular diseases such as atherosclerosis, restenosis, and transplant- associated arteriosclerosis in adulthood. Despite this high clinical significance, our incomplete understanding of the process of vascular remodeling limits current abilities to develop preventive and therapeutic strategies. Vascular smooth muscle cells (SMCs) are main drivers of developmental and adult vascular remodeling, but mechanisms underlying SMC activities are not fully elucidated — in particular, the role of mitochondria and metabolism in this context is relatively unexplored. The goal of this proposal is to understand mitochondrion-based mechanisms that regulate SMC phenotype in vascular remodeling. We have shown that the FAT1 cadherin interacts with and inhibits mitochondrial respiratory complex I, limits SMC proliferation by restraining mitochondrial respiration, and opposes vascular occlusion after arterial injury. These findings suggest that respiratory complex I regulates SMC behavior. Our new preliminary data further support this idea. Loss of complex I subunit NDUFS4 in cultured SMCs decreases complex I levels and activity, limits the formation of supercomplexes containing complex I, lowers aspartate levels, and impairs cell growth. In vivo, NDUFS4 is highly expressed during mouse development in SMCs building the arterial wall, and in adult mice in SMC-derived cells that form the expanding neointima that accumulates in response to arterial injury. Preliminary studies with selective NDUFS4 deletion in SMCs suggest that these cells require respiratory complex I for normal embryogenesis. We hypothesize that complex I promotes SMC activities important for vascular remodeling during embryogenesis and in adulthood. We will test this hypothesis in three specific aims that respectively address the effects of impaired respiratory complex I function 1) on key SMC activities, 2) on mouse vascular development, and 3) in models of adult vascular homeostasis, injury, and atherosclerotic disease. These studies will add a new respiratory complex-based angle — susceptible to pharmacological intervention — to our understanding of how arteries form and how they respond to injury, with relevance for tissue engineering, therapeutic angiogenesis, tumor vascularization, and vascular disease.

总结血管重塑是胚胎发育过程中动脉形成所必需的，血管疾病的发病机制，如动脉粥样硬化、再狭窄和移植- 与成年期动脉硬化有关。尽管有很高的临床意义，我们的不完整对血管重塑过程的理解限制了目前发展预防和治疗策略。血管平滑肌细胞（SMC）是血管平滑肌细胞的主要驱动力。发育和成人血管重塑，但SMC活动的机制是没有完全阐明-特别是，线粒体和代谢在这种情况下的作用，相对未开发。本提案的目标是了解基于Linux的在血管重塑中调节SMC表型的机制。我们已经证明， FAT 1钙粘蛋白与线粒体呼吸复合物I相互作用并抑制，限制SMC 增殖，抑制线粒体呼吸，并反对血管闭塞后，动脉损伤这些发现表明，呼吸复合物I调节SMC的行为。我们新的初步数据进一步支持这一观点。培养的细胞中复合物I亚基NDUFS 4的丢失 SMC降低复合物I水平和活性，限制超复合物的形成含有复合物I，降低天冬氨酸水平，并损害细胞生长。在体内，NDUFS 4是高度在小鼠发育过程中，在构建动脉壁的SMC中表达，在成年小鼠中， SMC衍生的细胞形成扩张的新生内膜，其响应于动脉粥样硬化而积聚。损伤SMCs中选择性NDUFS 4缺失的初步研究表明，这些细胞需要呼吸复合物I来进行正常的胚胎发生。我们假设复合物I 促进SMC活性，这对胚胎发生过程中的血管重塑和成年我们将在三个具体目标中检验这一假设，呼吸复合物I功能受损的影响：1）对关键SMC活性，2）对小鼠血管发育，和3）成人血管稳态，损伤，和动脉粥样硬化性疾病这些研究将增加一个新的基于呼吸复合体的角度- 易受药物干预的影响-我们对动脉如何形成和它们如何对损伤作出反应，与组织工程，治疗性血管生成，肿瘤血管形成和血管疾病。

项目成果

期刊论文数量（2）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Neutrophil extracellular traps in cardiac hypertrophy: a KLF2 perspective.

DOI：
10.1172/jci156453
发表时间：
2022-02-01
期刊：
The Journal of clinical investigation
影响因子：
0
作者：
Riascos-Bernal DF;Sibinga NE
通讯作者：
Sibinga NE

The FAT1 Cadherin Drives Vascular Smooth Muscle Cell Migration.

DOI：
10.3390/cells12121621
发表时间：
2023-06-14
期刊：
CELLS
影响因子：
6
作者：
Riascos-Bernal, Dario F.;Ressa, Gaia;Korrapati, Anish;Sibinga, Nicholas E. S.
通讯作者：
Sibinga, Nicholas E. S.